100
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy

, , , , &
Pages 185-191 | Published online: 26 Jan 2012

References

  • FongDSAielloLPFerrisFLIIIKleinRDiabetic retinopathyDiabetes Care2004272540255315451934
  • SinghRRamasamyKAbrahamCGuptaVGuptaADiabetic retinopathy: an updateIndian J Ophthalmol20085617818818417817
  • PerumalsamyNPrasadNMSathyaSRamasamyKSoftware for reading and grading diabetic retinopathy: Aravind Diabetic Retinopathy Screening 3.0Diabetes Care2007302302230617507695
  • AkdumanLOlkRJThe early treatment for diabetic retinopathyKertsCClinical Trials in Ophthalmology – A Summary and Practice Guide3rd edPhiladelphia, PALippincott1998
  • AielloLMCavalleranoJDAielloLPBursellSEDiabetic retinopathyGuyerDRYannuzziLAChangSRetina Vitreous Macula6th edPhiladelphia, PASaunders1999
  • TervaertTWMooyaartALAmannKPathologic classification of diabetic nephropathyJ Am Soc Nephrol20102155656320167701
  • RandLIPrud’hommeGJEdererFCannerPLFactors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10Invest Ophthalmol Vis Sci1985269839912409053
  • FongDSSegalPPMyersFFerrisFLHubbardLDDavisMDSubretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research GroupArch Ophthalmol19971158738779230827
  • The Diabetic Retinopathy Vitrectomy Study Research GroupEarly vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5Arch Ophthalmol19901089589642196036
  • The DCCT Research GroupHypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research GroupDiabetes1997462712869000705
  • UK Prospective Diabetes Study (UKPDS) GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupLancet19983528378539742976
  • Early Treatment Diabetic Retinopathy Study Research GroupGrading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research GroupOphthalmology1991987868062062513
  • Early Treatment Diabetic Retinopathy Study Research GroupFundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research GroupOphthalmology1991988238332062515
  • GarziaRBorstingENicholsonSPressLScheimanMSolanHOptometric Clinical Practice Guideline: Care of the Patient with Learning Related Vision Problems: Reference Guide for CliniciansSt Louis, MOAmerican Optometric Association2006
  • LiesegangTJSkutaGLCantorLBRetina and Vitreous25th edSan Francisco, CALEO Publication2004
  • FrankRNPotential new medical therapies for diabetic retinopathy: protein kinase C inhibitorsAm J Ophthalmol200213369369811992868
  • BhavsarARDiabetic retinopathy: the latest in current managementRetina200626S71S7916832305
  • FedermanJLGourasPSchubertHDSystemic diseasesPodosSMYanoffMRetina and Vitreous – Textbook of Ophthalmology24th edNew York, NYMcGraw Hill1994
  • PardiantoGUnderstanding Diabetic Retinopathy in Mimbar Ilmiah Oftalmologi Indonesia2005
  • FrankRNEtiologic mechanisms in diabetic retinopathyRyanSJRetina2nd edPhiladelphia, PALippincott1994
  • MurataTNakagawaKKhalilAIshibashiTInomataHSueishiKThe relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinasLab Invest1996748198258606491
  • LevyAPLevyNSWegnerSGoldbergMATranscriptional regulation of the rat vascular endothelial growth factor gene by hypoxiaJ Biol Chem199527013333133407768934
  • BattegayEJAngiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospectsJ Mol Med (Berl)1995733333468520966
  • ResnickHEHarrisMIBrockDBHarrisTBAmerican Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination SurveyDiabetes Care20002317610868827
  • FunatsuHYamashitaHNakanishiYHoriSAngiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathyBr J Ophthalmol20028631131511864890
  • HernandezCBurgosRCantonAGarcia-ArumiJSeguraRMSimoRVitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control studyDiabetes Care20012451652111289478
  • MalikRALiCAzizWElevated plasma CD105 and vitreous VEGF levels in diabetic retinopathyJ Cell Mol Med2005969269716202216
  • HernandezCLecubeASeguraRMSararolsLSimoRNitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathyDiabet Med20021965566012147146
  • SimoRLecubeASeguraRMGarciaAJHernandezCFree insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathyAm J Ophthalmol200213437638212208249
  • WatanabeDSuzumaKSuzumaIVitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathyAm J Ophthalmol200513947648115767056
  • SydorovaMLeeMSVascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathyOphthalmic Res20053718819015990461
  • Hogeboom van BuggenumIMPolakBCReichert-ThoenJWde Vries-KnoppertWAvan HinsberghVWTangelderGJAngiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathyDiabetologia20024520320911935151
  • AielloLPAveryRLArriggPGVascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med1994331148014877526212
  • DengJWuDZGaoRElevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathyYan Ke Xue Bao199915172112579655
  • AmbatiJChalamKVChawlaDKElevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathyArch Ophthalmol1997115116111669298058
  • ZhouHZhangHA comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathyZhonghua Yan Ke Za Zhi199733247250 Chinese10451953
  • AdamisAPMillerJWBernalMTIncreased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathyAm J Ophthalmol19941184454507943121
  • BurgosRSimoRAudiLVitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathyDiabetologia199740110711099300249
  • ShinodaKIshidaSKawashimaSClinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathyCurr Eye Res20002165566111148602